Chugai Commits $220M Into Singapore Drug Lab Post author:Sam Post published:December 28, 2017 Post category:BioPharma The drugmaker intends to expand development of therapeutic antibodies at the lab. Source: BioSpace You Might Also Like Eton Pharma Appoints To Its Board Of Directors September 7, 2017 Alzheon Launches IPO to Fund Alzheimer's Drug March 18, 2018 SpineGuard Looks to Break Even by 2018, Names Co-Founder CEO July 6, 2017
